This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

MorphoSys AG Company Information

MorphoSys AG's employee growth, exchange listings and data sources


Key Information

  • Name: MorphoSys AG
  • Ticker: MOR
  • Exchange: XTRA
  • Founded: 1992
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: €2.533b
  • Shares Outstanding: 37.66m
  • Website: https://www.morphosys.com

Number of Employees


Location

  • MorphoSys AG
  • Semmelweisstrasse 7
  • Planegg
  • Bavaria
  • 82152
  • Germany


Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
MORDB (Deutsche Boerse AG)YesOrdinary SharesDEEURMar 1999
MORXTRA (XETRA Trading Platform)YesOrdinary SharesDEEURMar 1999
0NDVLSE (London Stock Exchange)YesOrdinary SharesGBEURMar 1999
MPSY.FOTCPK (Pink Sheets LLC)YesOrdinary SharesUSUSDMar 1999
MORDBATS-CHIXE (BATS 'Chi-X Europe')YesOrdinary SharesGBEURMar 1999
MORSWX (SIX Swiss Exchange)YesOrdinary SharesCHCHFMar 1999
4MORETLX (Eurotlx)YesOrdinary SharesITEURMar 1999
MORBUL (Bulgaria Stock Exchange)YesOrdinary SharesBGEURMar 1999
MOR2DB (Deutsche Boerse AG)SPON ADS EACH REP 0.25 ORD SHSDEEURApr 2018
MORNasdaqGS (Nasdaq Global Select)SPON ADS EACH REP 0.25 ORD SHSUSUSDApr 2018

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/08/05 11:37
End of Day Share Price 2024/08/05 00:00
Earnings2024/03/31
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/08/05 11:37
End of Day Share Price 2024/08/05 00:00
Earnings2024/03/31
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

MorphoSys AG is covered by 35 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Olav ZilianBaader Helvea Equity Research
Brian BalchinBarclays
Rosie TurnerBarclays